These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10208577

  • 1. Serotonergic agonists behave as partial agonists at the dopamine D2 receptor.
    Rinken A, Ferré S, Terasmaa A, Owman C, Fuxe K.
    Neuroreport; 1999 Feb 25; 10(3):493-5. PubMed ID: 10208577
    [Abstract] [Full Text] [Related]

  • 2. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg, Mikaels, Mohell N.
    J Pharmacol Exp Ther; 1998 Apr 25; 285(1):119-26. PubMed ID: 9536001
    [Abstract] [Full Text] [Related]

  • 3. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 4. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 27; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 5. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
    Jerning E, Rosqvist S, Mohell N.
    J Recept Signal Transduct Res; 2002 Jul 27; 22(1-4):483-95. PubMed ID: 12503636
    [Abstract] [Full Text] [Related]

  • 6. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
    Roberts DJ, Lin H, Strange PG.
    Biochem Pharmacol; 2004 May 01; 67(9):1657-65. PubMed ID: 15081865
    [Abstract] [Full Text] [Related]

  • 7. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 01; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 8. Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors.
    Terasmaa A, Finnman UB, Owman C, Ferré S, Fuxe K, Rinken A.
    Neurosci Lett; 2000 Feb 18; 280(2):135-8. PubMed ID: 10686396
    [Abstract] [Full Text] [Related]

  • 9. Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays.
    Gilliland SL, Alper RH.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 18; 361(5):498-504. PubMed ID: 10832603
    [Abstract] [Full Text] [Related]

  • 10. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T.
    Eur J Pharmacol; 1996 May 15; 303(3):151-62. PubMed ID: 8813561
    [Abstract] [Full Text] [Related]

  • 11. Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
    Pauwels PJ, Tardif S, Wurch T, Colpaert FC.
    Br J Pharmacol; 2001 Sep 15; 134(1):88-97. PubMed ID: 11522600
    [Abstract] [Full Text] [Related]

  • 12. Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor.
    Lin H, Saisch SG, Strange PG.
    Br J Pharmacol; 2006 Oct 15; 149(3):291-9. PubMed ID: 16921389
    [Abstract] [Full Text] [Related]

  • 13. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ.
    Mol Pharmacol; 1999 Mar 15; 55(3):564-74. PubMed ID: 10051542
    [Abstract] [Full Text] [Related]

  • 14. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032
    [Abstract] [Full Text] [Related]

  • 15. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E, Li H, Carr KD, Hiller JM.
    J Pharmacol Exp Ther; 2000 Feb 15; 292(2):684-91. PubMed ID: 10640306
    [Abstract] [Full Text] [Related]

  • 16. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 17. Stimulated [35S]GTP gamma S binding by 5-HT1A receptor agonists in recombinant cell lines. Modulation of apparent efficacy by G-protein activation state.
    Pauwels PJ, Tardif S, Wurch T, Colpaert FC.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov 30; 356(5):551-61. PubMed ID: 9402034
    [Abstract] [Full Text] [Related]

  • 18. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
    Newman-Tancredi A, Chaput C, Verrièle L, Millan MJ.
    Eur J Pharmacol; 1996 Jun 20; 307(1):107-11. PubMed ID: 8831111
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):348-56. PubMed ID: 17070976
    [Abstract] [Full Text] [Related]

  • 20. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 30; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.